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Abstract
Background: Primary ciliary dyskinesia (PCD) is a chronic respiratory disease for which there is little
psycho-social research and no qualitative studies of individuals living with the condition. A questionnaire-
based survey in 2003 found evidence of stigmatisation in some individuals with PCD. Although the
questionnaire had face and construct validity, stigmatisation was not cross-validated against interviews.
The present study had the twin aims of carrying out a qualitative study of the adult patients living with
PCD, and using a structured design to validate the questionnaire measure of stigma.
Methods: Interviews were carried out with six pairs of individuals with PCD, matched for sex, situs, and
age, one with a high stigma score in 2003 and the other with a low stigma score. Depth-qualitative
interviews were conducted by one author to explore themes surrounding the psycho-social impact of
PCD using a grounded theory analysis. The interviewer was blind to the stigma scores of participants, and
after the qualitative analysis was completed, the interviewer made an assessment of which member of each
pair seemed the more stigmatised, after which the code was broken.
Results: Interviews revealed a number of themes, including other people's knowledge of PCD, the sharing
of knowledge about PCD, the concealment of symptoms of PCD, embarrassment at symptoms, changes
of behaviour in response to PCD, mistrust of medical care, in particular in relation to problems in
diagnosis, a mistrust of general practitioners who were seen as poorly informed, and the importance of
expert care at tertiary referral centres. Although stigmatisation as such was rarely mentioned directly by
respondents, when the interviewer's judgement on level of stigmatisation was correlated with stigma
scores from 2003, it was found that the more stigmatised member had been correctly identified in all six
pairs (p = .016).
Conclusion: Our results suggest that some people with PCD feel isolated through mistrust in medicine,
and lack of knowledge surrounding PCD. Many responses to PCD can be explained in terms of
stigmatisation, and in particular felt stigma. The correlation between questionnaire used several years
previously, and the interviewer's judgements of stigmatisation suggest that the stigma questionnaire had
both predictive validity and long-term stability. As in other chronic conditions, stigmatisation occurs only
in some individuals with PCD, and the present study explores the basis of stigmatisation, and validate the
questionnaire as a measure of difference in stigma.
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Background
Primary Ciliary Dyskinesia (PCD) (immotile cilia syn-
drome, Kartagener's or Siewert's Syndrome [1-3]), is a
chronic respiratory disorder with a prevalence of about 1
in 15,000 – 30, 000 [4,5], usually inherited as an auto-
somal recessive [6,7]. Patients have abnormal or absent
cilia, characterised by abnormal morphology of the 9 + 2
system of dynein arms [8]. Coordinated beating of respi-
ratory tract cilia is disrupted, so that detritus from lungs
and sinuses is not removed, resulting in chronic sinusitis,
bronchiectasis and hearing problems. Dysfunctional beat-
ing of spermatozoa tails also causes infertility in males.
Classically, Kartagener's Syndrome also shows left-right
reversal of the viscera, situs inversus totalis (SI), in contrast
to the normal arrangement (situs solitus, SS). The ciliary
defect in PCD probably also occurs in the nodal cilia of
the embryo determining situs. Disruption of normal right
to left flow in PCD randomises situs, half of individuals
showing SI and half SS [9-11,11]. Prognosis in PCD is
good, with a normal life expectancy [12].
Diagnosis of PCD can be problematic, with wide variation
in symptoms and scarcity of diagnostic facilities [4]. Age
at presentation in one study varied from 4 months to 51
years [13]. Occasionally diagnosis is early, when associ-
ated with neonatal pneumonia [14]. There is currently no
cure, treatment emphasising symptomatic relief, antibiot-
ics for bronchitis, pneumonia and bronchiectasis, and reg-
ular physiotherapy, including postural drainage and chest
percussion.
Despite relatively high numbers of patients with PCD –
perhaps 3,000 in the UK and 12,000 in the United States
– there are few studies of its psycho-social impact; apart
from our own work [11,15], we know of only one per-
sonal report on the condition [16]. However, there are
studies of psycho-social factors in related conditions, par-
ticularly cystic fibrosis (CF), a disease with parallels to
PCD, including a genetic basis, chronic respiratory diffi-
culties and fertility problems, although the far worse prog-
nosis in CF limit the utility of the comparison [17,18]. In
CF, diagnostic delay frustrated patients, both in child-
hood [19], and also, as is not uncommon in PCD, when
diagnosis was delayed until adulthood [20,21], causing
negative views of medicine, negative impacts on family
life, less compliance with medication [22], and a need for
information [21]. In childhood, CF resulted in problems
in understanding the condition, in being "teased and
picked on" [23] and telling others about the diagnosis
[23,24]. However progressive deterioration in CF also
produces specific problems, particularly in the transition
to adulthood [25-29], a problematic time for all chronic
chilhood conditions [30]. Although attitudes to chronic
obstructive pulmonary disease (COPD) might be thought
to overlap with PCD, the main problem in COPD is
breathlessness [31], whereas cough predominates in PCD.
All chronic conditions put demands upon those with
them. Qualitative research talks of the need to "achieve
harmony with oneself" [32], and the difficulties of "hov-
ering between suffering and enduring" [33]. Patients vary
in their coping, with some identifying particular turning
points and protective processes [34]. There is a recurrent
realisation that doctors are ill-informed about the needs
of chronic illness patients [35,36], and as patients with
asthma put it, "We are the experts" [37], self-care being the
norm [38]. PCD has the additional burden of a genetic
component which adds to perceived problems of individ-
uals and families [39]. Theoretical analyses of responses
to chronic illness (such as the transactional model [30]),
and models invoking loss and grief (see Sidell's review
[40]), have little direct relevance to PCD, since although
chronic, PCD is not acquired in adulthood but congenital,
so there cannot be loss, grief or mourning as such, as
nothing has been lost. Instead adjustment requires an
acceptance of difference and deficit in childhood, which is
perhaps best understood using the concept of stigma.
Elsewhere we have suggested that the impact of PCD upon
psycho-social well-being [11], might be explained in
terms of [15]. Of particular interest, is that since half of
individuals with PCD have situs inversus, a physical but
concealable bodily abnormality, decisions have to be
made about revealing this atypicality to others [15]. The
present study therefore included some subjects with situs
inversus.
Erving Goffman's Stigma: Notes on the Management of
Spoiled Identity [41] defined stigma as a mark that identi-
fies the target individual as spoiled in some way (italics are
used to indicate Goffman and others' technical terminol-
ogy). This spoiled identity, through the stigma mark, deval-
ues the individual in comparison to non-stigmatised
individuals. Goffman identified three types of stigma:
abominations of the body for physical problems such as
facial blemishes, disability or stuttering; blemishes of indi-
vidual character for character traits such as homosexuality,
criminal behaviour, or radical political beliefs; and tribal
stigmas such as race, religion, or nationality.
Individuals with PCD have no obviously visible stigmata
(although the chronic cough is an audible sign). More rel-
evant in Goffman's theoretical analysis is his differentia-
tion of those whose stigma mark is instantly perceivable –
discredited individuals – from those is not perceptible or
known about – discreditable individuals. Although the latter
have no problem of an obvious stigma mark, they still
face problems of information management, decidingBMC Pulmonary Medicine 2006, 6:25 http://www.biomedcentral.com/1471-2466/6/25
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whether to divulge information, or to conceal the spoiled
identity.
All recent work builds upon Goffman, although sociolo-
gists and social psychologists have different perspectives
[42]. Jones et al [43] identified six separate components of
stigma: Concealability – whether perception is necessary
and inevitable; Course of the mark – the progressive devel-
opment of the stigma mark; Disruptiveness – interference
of social interactions; Aesthetics – the extent to which oth-
ers are repulsed; Origin – perceived responsibility for the
stigma mark; and Peril – possible dangers posed by the
stigmatised person. A separate theoretical distinction,
developed in a study of epilepsy by Scambler and Hop-
kins [44], differentiated public acts and outcomes of
enacted stigma, from the more complex, personal shame
experienced in felt stigma. Other theoretical facets include
aspects of stigma and stereotypes [45], prejudice [46],
embarrassment [47], and social control [48].
Measurement of stigma has proved problematic, particu-
larly using questionnaires, which have focussed on topics
as family relations, social interaction, and self-esteem
[49], or retreat, self-esteem, rejection, concealment, and
composure [50]. A review by van Brakel [51] emphasised
that "the consequences of stigma are remarkably similar
in different health conditions", implying a generic instru-
ment should be possible, and justifying sharing question-
naire items across conditions, as we did in our previous
study [15], developing a scale (see Table 1), which
adapted items from a scale developed for people with Par-
kinson's disease [52]. Factor analysis showed a single
underlying dimension. Path analysis found that neither
physical symptoms nor the presence of SI related to per-
ceived stigmatisation in PCD, whereas personality, men-
tal health status, and social impact did predict stigma
levels.
Although our previous study [15] had developed a stigma
questionnaire with face and construct validity, there was
no direct validation. The present study therefore had two
separate aims: to use qualitative methods to explore per-
sonal responses to PCD, with the particular possibility of
stigma; and to use a quasi-experimental design for directly
validating the stigma questionnaire.
A literature search found no qualitative studies of PCD,
and so we used a grounded theory approach. Grounded
theory [53], which comes in several 'flavours' [54], is use-
ful for capturing patient perspectives and understanding
the meanings people attach to their social world. In gen-
eral, grounded theory should not involve a priori theoret-
ical influences, allowing specific themes, in our case on
PCD in general and the possibility of stigma, to emerge
through the data collection and analysis process [54].
The present qualitative study followed-up participants
from the original quantitative study, in a purposive,
matched-pairs design, one member of each pair in 2003
having a high stigma score and the other a low score. A key
feature of the study is that all interviews, transcriptions
and interpretations of qualitative data were made by SW,
who did not have access to the original questionnaire
data, whereas the pairs of interviewees were chosen by
ICM, who did not take part in the grounded theory analy-
sis. Only when grounded theory analysis was complete
did SW rate the extent of stigma in the pair members, the
similarity of those ratings to the original stigma scores
assessing both the validity and long-term reliability and
stability of the questionnaire.
Table 1: The questions used to assess stigma, which were embedded amongst other questions on respiratory problems and health in 
general.
These are questions about other effects that breathing or respiratory 
problems may have. If you do not have a particular problem then please tick 
'Not applicable'.
Definitely agree Agree somewhat Disagree 
somewhat
Definitely 
disagree
N/A Factor 
loading
My coughing or breathing is embarrassing in public 37.3% (25/67) 37.3% (25/67) 13.4% (9/67) 11.9% (8/67) N = 4 .530
My breathing problem is a nuisance to my family, friends, or neighbours 15.6% (10/64) 17.2% (11/64) 18.8% (12/64) 48.4% (31/64) N = 7 .478
I have sometimes felt I had to hide from other people the fact that I had PCD 25.4% (17/67) 19.4% (13/67) 10.4% (7/67) 44.8% (30/67) N = 4 .880
I have sometimes felt embarrassed in public because of having PCD 21.2% (14/66) 28.8% (19/66) 12.1% (8/66) 37.9% (25/66) N = 5 .818
I have sometimes avoided situations where people might find out that I had PCD 23.1% (15/65) 13.8% (9/65) 6.2% (4/65) 56.9% (37/65) N = 6 .863
I have sometimes felt worried about other people's reaction to PCD 21.2% (14/66) 24.2% (16/66) 13.6% (9/66) 40.9% (27/66) N = 5 .866
How does PCD affect your daily life? True False N/A Factor 
loading
I sometimes feel it makes people reject me 18.8% (13/69) 81.2% (56/69) N = 2 .586
Sometimes it makes it more difficult for me to make friends 16.2% (11/68) 83.8% (57/68) N = 3 .592
It is sometimes difficult telling people about my condition 43.5% (30/69) 56.5% (39/69) N = 2 .860
Sometimes I prefer not to let other people know that I have PCD 59.4% (41/69) 40.6% (28/69) N = 2 .710
Sometimes it is difficult having a rare and unusual condition 56.5% (39/69) 43.5% (30/69) N = 2 .622
The descriptive statistics are taken from our previous paper [15], and show the percentage of individuals giving each of the answers, along with the 
loading of each measure on the single factor that was extracted in that analysis. NA = "not applicable"BMC Pulmonary Medicine 2006, 6:25 http://www.biomedcentral.com/1471-2466/6/25
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Methods
Sampling and recruitment
In January 2003, 160 members of the UK Primary Ciliary
Dyskinesia Support Group with diagnosed PCD were sent
a 16-page questionnaire covering a wide range of topics,
including mental and physical health status [15]. The 93
completed questionnaires form the primary sampling
frame for this study.
ICM was responsible for choosing participants. Figure 1
shows stigma scores in 2003 in relation to participants'
age in 2005, when this study was carried out. Individuals
under the age of 18 were excluded for ethical reasons, and
for practical reasons individuals included lived within 250
kms of London. Pairs were identified with one 'high'
stigma scorer (≥ 1) and one 'low' stigma scorer (≤ 0), each
with the same situs and sex, and where possible, ages
within ten years of one another. SW contacted partici-
pants by letter and then phone. Figure 1 shows age and
stigma scores for the eventual six pairs. The database con-
tained more females than males, and matching male pairs
was difficult. Ill health caused the late withdrawal of one
male participant and when another match was found the
ages were somewhat discrepant (42 and 65). Although the
original study design looked for seven pairs (fourteen par-
ticipants), pair six was eventually dropped because a fur-
ther match could not be found after one participant
dropped out. The results here describe six pairs (labelled
1,2,3,4,5 and 7), aged from 27 to 65 (mean 49.8), and
three pairs showing SI. Table 2 summarises the demogra-
phy, and Table 3 shows 2003 responses to the St George's
Hospital Respiratory Questionnaire [55] and the derived
scales of the SF-36 health questionnaire [56,57].
Interviews
Using a grounded theory analytical approach (see below),
depth-qualitative interviews were conducted to allow for
a full exploration of themes surrounding the psycho-
social impact of PCD. All interviews were conducted by a
single interviewer (SW) who was blinded to the original
stigma scores until full coding and analysis had been com-
pleted. A prompt card was used by the interviewer during
each interview to ensure that key areas were covered. Inter-
views were conducted between July 2005 and January
2006 (hereafter '2005'), lasted 40 to 60 minutes and were
recorded and transcribed for analysis. Eleven interviews
were conducted in participants' homes, and one in the
UCL Psychology Department.
Three pilot interviews ensured that SW understood the
key symptoms, treatments and experiences of people with
PCD. While the first two pilot interviews focussed on
symptoms and diagnosis, the final pilot interview
included more in-depth psycho-social issues concerning
PCD, and this interview was included in the final analysis
(participant 3A).
Grounded theory analysis
To ensure data collection was truly grounded, analysis was
carried out between interviews, as well as after all inter-
views were completed [58]. Initial themes under investi-
gation included diagnosis, symptoms and social
perspectives surrounding PCD, including the possibility
of stigma. To ensure theories and concepts were grounded
in collected data [54] the focus of the interviews changed
as themes emerged during the data collection phase, while
other themes were replaced when saturation was reached
and new information was not forthcoming. Before each
interview the previous interview was fully transcribed and
loosely open-coded, with emerging themes compared and
contrasted to previous interview data. A field journal was
updated following each interview to capture any new
themes emerging, and where relevant these themes guided
subsequent interviews and analysis.
After data collection the complete transcriptions were
comprehensively open-coded to formulate a list of key
themes that may affect levels of stigma in people living
with PCD. Data were initially grouped within five themes:
knowledge of PCD; management of PCD; the 'self'; living
with PCD; and support. Following subsequent coding and
analysis, key themes were finally grouped within three
main categories: knowledge surrounding PCD; conceal-
ment of PCD; and mistrust of medical care. Anonymised
participants' extracts are used in the qualitative results sec-
tion of this report, based information on each participant
being presented in the form [2B: 61F, SI, high], indicating
[Pair identifier; Age and sex, situs, stigma score].
Stigma ratings
When qualitative data had been coded and analysed, SW
rated each participant on a four-point scale for perceived
stigma (1: no perceived stigma, through 4: high perceived
stigma). These ratings, which were blind questionnaire
stigma scores, were based upon an informal subjective
analysis of psycho-social themes within the qualitative
data, including self-reported symptom concealment, trust
in medicine, and current and past social support. For clar-
ity, quantitative, questionnaire-based stigma assessments
in 2003 are referred to as stigma scores, whereas interviewer
assessments of stigma in 2005 are referred to as stigma rat-
ings.
Un-blinding and comparison of stigma scores
When SW had made his stigma ratings, ICM revealed the
original questionnaire-based stigma scores, and scores
and ratings compared. Although our original study design
allowed SW to re-analyse transcripts in the light of dis-BMC Pulmonary Medicine 2006, 6:25 http://www.biomedcentral.com/1471-2466/6/25
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crepancies between stigma scores and ratings, that in fact
was not required.
Ethics and confidentiality
Ethical approval was granted by the University College
London Hospital Local Research Ethics Committee. Par-
ticipants provided informed consent, were fully briefed
on the study, told they could withdraw at any time, and
that interviews would be recorded and transcribed and
were fully confidential. Participants received no payment
for taking part, but were thanked for their time.
Results
i) Qualitative findings
Knowledge of PCD
Other people's knowledge of PCD
When asked about other people's knowledge of PCD, all
participants said other people knew little or nothing
about PCD, although feelings were mixed about this.
Most participants accepted that the low prevalence of PCD
meant there would be a paucity of public knowledge, but
nevertheless some participants spoke of frustration that
lack of knowledge led to lack of support and understand-
ing:
"...it's frustrating when you need the treatment and if
you're feeling rough people don't understand some-
times, things like that but it is how it is and you have
to deal with it the best way you can, don't you." [1B:
57F, SI, high]
"I don't know anyone who's got the condition, I don't
know anyone who's got a chest complaint even, not a
chronic one, apart from a few touches of asthma. I
suppose it's horrible really but they make an awful fuss
and, but no, it's lonely, if you have cancer [...] most
people know someone else and you have a sort of sup-
port through that but this is an odd one, chronic chest
condition..." [2B: 61F, SI, high]
However one participant spoke of an advantage of having
a rare condition such as PCD:
"Well, other people are very interested because it's
quite an interesting condition to have, especially being
so rare." [1A, 54F, SI, low]
Sharing knowledge of PCD
Some participants used cystic fibrosis to anchor under-
standing about PCD:
"And you can always fall back on the well it's a disease,
the symptoms are not dissimilar to cystic fibrosis
because everybody's heard of CF these days." [1A: 54F,
SI, low].
There was also a link between educating others about PCD
and disclosing details of their own condition:
"...so if I tell someone I've got it I have to explain what
it is." [5A: 27F, SS, low].
This produced a dilemma for some participants about
whether to disclose, and how much information should
be given. One participant's example of disclosure seemed
open and uncensored by containing references to possible
stigmatising signs:
"...normally say, you know, I've got, I've got this thing
called PCD and it's, basically I go you know the little
hairs in your body or cilia that waft along in your
bronchial tubes and your nasal passages and they go
no (laughs). Well anyway, your tubes are lined with
microscopic hairs and they waft all the muck out and
keep your lungs clear and I say well mine don't work
properly and so, you know, I get all the muck and
obviously it's not very good for the lungs, or lung, and,
yeah, but just explain it layman's terms." [4B: 51F, SS,
low]
Another participant seemed comfortable with people
finding out about all symptoms of PCD either via the
internet or through personal disclosure (interviewer com-
ments in italics):
Interviewer "And do you actively kind of educate people
about it [PCD] sometimes?
"Yeah, I do. If I, I mean obviously I would make sure
that I explained it so that they know that they exist and
[...] if they asked me questions then I would try and
tell them and I might refer them to the website or
something." [5A: 27F, SS, low]
However, most participants conducted varying levels of
information management. Information regarding PCD
often seemed to be self-censored by avoiding revealing
outwardly stigmatizing signs, such as a chronic cough or
excessive nose blowing:
Interviewer: "What are the main points that you might tell
them about?
"Oh, about the immotile cilia, I mean everybody I've
come across knows that my [...] heart's in the right and
liver's on the left so that's fairly basic and everybody's
interested in that but I won't go into details about pro-
ductive cough because that's not something people
want to know about." [1A: 54F, SI, low]BMC Pulmonary Medicine 2006, 6:25 http://www.biomedcentral.com/1471-2466/6/25
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"I might tell them about the.., I might tell them the,
you know, name of it. I just hope they won't look it up
(laughs). But I don't tell them the actual symptoms. I
might say about the cilia not working, but I don't actu-
ally say the consequences of that." [1B: 57F, SI, high]
"I would, well if I say anything I would just say it
affects the cilia that are in your lungs so that they don't
beat properly and the, as a result you get lung dam-
age." [4A: 53F, SS, high]
There were differences in reasons for disclosing informa-
tion about the condition, one participant talking of a ben-
efit in being open and educating others about their PCD:
"I think it's important they understood, and the more
you tell people about it, the more you feel you know
about it yourself." [7B: 65M, SS, low]
However, there were also situations where there was a felt
pressure to disclose:
"...because I've told my neighbours mainly because I
think some of them wonder why I haven't had any
children." [2A: 65F, SI, low]
"I've been going to yoga and again I've got into my
loop of trying to hide it and quite recently I did tell the
teacher in detail, not in detail in two sentences and
what had happened was they'd had a stand-in teacher
who had made a spectacle of me saying oh, why aren't
you doing that and why can't you do that and I said
well I can't do it because it's too strenuous and I
thought oh I'm just going to have to tell them really."
[2B: 61F, SI, high]
Table 2: Demographic details of participants in matched pairs, along with stigma scores from the questionnaire in 2003 and ratings of 
stigma by the interviewer in 2005.
Participant code Sex Age at 
interview
Age at diagnosis Situs inversus Stigma score 
based on 
questionnaire in 
2003 (higher 
scores indicate 
higher stigma)
Stigma rating of 
interviewer in 
2005. 1 indicates 
low perceived 
stigma and 4 
indicates high 
perceived 
stigma.
1 AF 5 43 2Y e s - . 4 61
1 BF 5 72 3Y e s 1 . 6 14
2 AF 6 55 8Y e s - . 3 72
2 BF 6 15 0Y e s 2 . 0 53
3 AF 4 93 4Y e s - . 0 81
3 BF 4 22 2Y e s 1 . 9 14
4 BF 5 34 3N o - . 1 81
4 A F 5 13 6N o 1 . 5 14
5 AF 2 71 1N o - . 8 71
5 BF 3 21 0N o 1 . 1 63
7 BM 4 23 5N o - . 7 31
7 A M 6 55 6N o 2 . 0 54
Within each pair the low stigma individual based on the questionnaire is shown in italics and the high stigma individual in bold. It should be noted 
that individuals were randomly allocated as A or B using random number tables.
Questionnaire-based stigma scores in relation to age, for all  participants in the 2003 questionnaire Figure 1
Questionnaire-based stigma scores in relation to age, for all 
participants in the 2003 questionnaire. Participants taking 
part in the current study are indicated by squares, with open 
squares for males and solid squares for females, and their 
pair membership shown.
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"I don't go out my way to tell people I've actually got
anything wrong with me but obviously people I might
be working close with, you know, if I have had a spell
in hospital obviously then they're going to want to
know why..." [4B: 51F, SS, low]
Some participants had at some point avoided disclosure,
or been discouraged to do so, and this was particularly
salient at school:
"...but, yeah, at school I did [have time off ill], you
know [...] at senior school I used to, it was an age thing
where I didn't want to admit to my friends that I had
anything wrong with me and I'd say oh I've got a cold,
I can't get rid of it, and I'd never talk about it so conse-
quently I just carried on doing the same kind of stuff
that they did. And I just couldn't keep up." [3B: 42F,
SI, high]
"... I know at one point the headmistress of the gram-
mar school I was at wrote to my mum and said why
was I having so much time off and she wrote back and
said I had bad periods which wasn't true at all so there
was this sort of hiding it which I don't, I think there's
a bit of a fine divide between cosseting somebody too
much and letting people understand that you actually
can't do things for a reason." [2B: 61F, SI, high]
Concealing PCD
Hiding the symptoms of PCD
Of the twelve participants, nine had at some time
attempted to conceal symptoms of PCD. Of the remaining
three, two were in the low stigma group (1A and 7B) and
one in the high stigma group (2B). 1A and 2B said it was
simply too hard to conceal a cough (see below), while 7B
had concealed symptoms only as a child. Other partici-
pants also tried to hide symptoms when younger:
Interviewer: "Can you remember what you might have done
at the time, if you needed to cough?
"I would go out. I would try and pretend that you
know, I would try and hold back from, you know,
where you try and hold back from coughing and you
try not to cough and then it gets worse and it escalates,
and then it all explodes out, [...] that sort of thing
would happen. Or I would go out the room or go away
and cough." [3B: 42F, SI, high]
"...so I just used to hold my breath, try and hold my
breath in class and watch the clock. Because obviously
if I breathed too quickly or too deeply I might start
coughing so I used to sort of sit there and (laughs) just
praying to god that I would reach the end of the lesson
without coughing, and then go out to the loo." [1B:
57F, SI, high]
Table 3: Clinical details of participants in matched pairs, assessed by questionnaire in 2003.
St George's Respiratory Questionnaire SF-36 component scores
Participant Symptoms Activity Impact Physical Mental
1A 54 72 63 47 56
1B 39 88 69 38 33
2A 11 88 73 19 52
2B 32 50 43 26 32
3A 64 81 77 46 45
3B 29 81 74 57 28
4B 11 38 57 32 58
4 A 7 3 44 21 83 5
5A 79 59 95 56 41
5B 39 78 70 42 31
7B 39 69 98 60 28
7 A 7 7 86 12 74 7
High stigma: mean (SD) 42.9 (28.0) 67.7 (17.8) 77.0 (16.4) 43.1 (15.3) 46.5 (11.2)
Low stigma: mean 
(SD)
25.6 (14.9) 68.2 (21.0) 59.9 (14.3) 34.7 (14.0) 34.5 (6.8)
Paired t-test t (5) = 1.83 t (5) = -.047 t (5) = 2.53 t (5) = 1.30 t (5) = 1.84
p = .126 p = .964 p = .053 p = .249 p = .125
Within each pair the low stigma individual based on the questionnaire is shown in italics and the high stigma individual in bold.BMC Pulmonary Medicine 2006, 6:25 http://www.biomedcentral.com/1471-2466/6/25
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Participants particularly attempted to hide coughing and
nose-blowing. As well as concealing symptoms at school,
some participants also described current attempts at hid-
ing outward signs of PCD:
"I do things like if we're in a restaurant or something
I'll go to the loo and cough in there except sometimes
the friend will come with me and I'll think oh no, so
that I go later. And I do thing like that just to try and
deal with it privately as possible." [4A: 53F, SS, high]
"I'll blow my nose in the toilets generally if I'm out
anywhere I'll blow my nose in the toilet so I cough in
the toilets, I'll go anywhere other than be around other
people, because I know people don't like to hear it
and, you know, so I, yeah, I've tried to disguise and
hide and quiet it, and almost always, almost always."
[7A: 42M, SS, high]
One participant described how, when younger, she hid
her cough for practical reasons:
"probably from my mum to avoid going to the doctors
or to avoid having physio..." [5A: 27F, SS, low]
However, two participants were pragmatic regarding their
symptoms when asked if they had ever attempted to hide
their PCD:
"...no I don't think so...well no, it's very hard to sup-
press a cough anyway. And if you've got a cough and a
wheeze you've got a cough and a wheeze, there's not
much you can do to suppress that". [1A: 54F, SI, low]
"Bit difficult (laughs). I can't. Because if you've got a
cough, you've got to cough. If you've got to blow your
nose, you've got to blow your nose so I can't. No. I feel
sorry for people hearing me sometimes but most peo-
ple have been very good at not noticing it." [2B: 61F,
SI, high]
Embarrassment at PCD symptoms
One participant who concealed her symptoms summed
up her feelings when asked how PCD affected her at
school and work:
"Oh, it made me feel like a dirty old man, quite hon-
estly. I think that says it all honestly." [1B: 57F, SI,
high]
The reasons of some participants for concealing symp-
toms suggested felt stigma, with excessive coughing seem-
ing to be the main concern:
"I suppose it's not very...actually coughing up mucus
isn't a very nice thing. It's not, it's quite a sort
of...frowned on in society kind of thing isn't it so I
kind of, yeah, I don't think it's very nice, sort of, to do
it in front of people, so, yeah, I don't know that I'm
scared about people finding out particularly but, yeah,
just...yeah, don't know, not really thought about why,
you know, why. But isn't just that it, yeah, doesn't
seem like a very nice sort of social thing to do and that,
maybe would think differently of you, or kind of,
yeah, look at you differently..." [5B: 32F, SS, high]
"So as a child my nose ran constantly, I would take to
school a pile of large handkerchiefs, and, you know, I
wanted to cough all the time basically, yes, but I tried
to suppress it because I was very embarrassed by it."
[1B: 57F, SI, high]
Interviewer: "And can you remember why you first started
doing it [hiding the symptoms]?
"Because people used to, sort of, because as you cough
people sort of give you a funny look and the eyebrows
wrinkle up and I knew that they found it unpleasant
and certainly as far as dating and things like that, it was
something I had to be, I, it's quite something for some-
one to get used to really..." [7A: 42M, SS, high]
Behaviour change
Participants concealing symptoms also described chang-
ing behaviour in order to conceal, as when a participant
missed postural drainage sessions:
"...this is probably going to sound ridiculous but like,
if we go to stay with friends for a weekend I don't do it
[postural drainage] because if I could do it silently I
would, but I can't..." [4A: 53F, SS, high]
Another participant talked of problems when younger
and on holiday:
Interviewer: "You mentioned holidays earlier on, but why
do they present a problem or a fear for you?
"Well, because of the, you know, postural, well, I
didn't do postural drainage in those days, but I went
on a camping holiday with friends and parents. It was
a nightmare because obviously then I didn't know
how to deal with it I suppose I was about, don't know,
thirteen or something, and, you know, trying to cough
in a tent (laughs). It was so embarrassing. So when
they asked me next year, I didn't go on holiday. That
was it really. And I didn't even go on days out like
school outings. I went once, you know, and, youBMC Pulmonary Medicine 2006, 6:25 http://www.biomedcentral.com/1471-2466/6/25
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know, it just wasn't worth it. So, I got used to not going
on holidays." [1B: 57F, SI, high]
In contrast, one participant who had never concealed
symptoms was open about her condition and treatment:
"I think I've become, I've become more aware of it
[treatment]. I'm more aware that exercise isn't an
option, or it isn't shall I or shan't I. I'm beginning to
be aware that, especially since I started having bone
density scans [for osteoporosis secondary to earlier
steroid treatment], that, that this, this is serious stuff,
and I know that if I do the exercise and I'll be half-way
home and I'll cough and I'll that blob of phlegm that's
blocking some airway somewhere, well that's good."
[1A: 54F, SI, low]
Whilst some participants' behaviour had been largely
unaffected by PCD, others' behaviour was highly dis-
rupted. Some participants reported career changes to
avoid poor air conditions or because of enacted or felt
stigma. One participant who appeared unaffected by felt
stigma had nevertheless left a job because of poor condi-
tions:
"...when I first left school I worked at [a car company]
showroom not far from here and I think I'd only been
there six months, the trouble was I worked in a small
office with a heavy smoker and within about six
months I did get pneumonia so I got pneumonia
when I was seventeen, I was quite poorly with that,
then I left there because I'd decided maybe heavy
smoking wasn't good for me..." [4B: 51F, SS, low]
Situs inversus
Although the situs inversus shown by many people with
PCD might seem to have the potential for being stigmatis-
ing, none of the participants saw it in that way, merely see-
ing it as being interesting:
"Interviewer: Did you feel different in any way at all at
school?
Er hmm (long pause) not until I suppose in my teens
when I I knew it was the wrong way round inside but
that was quite nice because that felt quite special.
Interviewer: Right
(unintelligible) James Bond's heart is the other way
round as well you know you sort of think 'wooh'. [...]
So I was just able to say 'Oh I'm the wrong way round
inside.' Not a big attraction really to any people." [3A:
49F, SI, low]
Mistrust of medical care
Uncertainty of diagnosis
Many participants experienced uncertainty over diagnosis,
with age at diagnosis ranging from 10 to 58, and most par-
ticipants experiencing bronchiectasis or other problems
before a diagnosis was reached. Failure to diagnose PCD
early left many participants with a mistrust of medical
care:
"I had so many conflicting things that I was told, and
then when I was nineteen I was told that by the time I
was thirty I would be permanently in a wheelchair and
on oxygen, and I mean at the time I was quite upset by
it, and so I suppose I've learnt to take a big pinch of
salt with what any medical person tells me." [4A: 53F,
SS, high]
"What I will say if I suppose, I've only got really one
thing to say, I think [...] doctors don't always like to
admit that they don't know something, do they. And I
think when I was younger, you know, if they'd said
they didn't know [...] and perhaps I'd have more help
in how to manage it, even if they didn't know what it
was. That would have been really helpful." [1B: 57F,
SI, high]
Interviewer: "When were you first diagnosed with PCD?
"I don't know. One of these things that I've drifted into
an awareness of it. I think for most of my childhood,
teenage years, young adult it was labelled as bronchial
asthma. I rather have a feeling that they didn't think it
was bronchial asthma but they put a label on it...for
the sake of putting a label on it." [1A: 54F, SI, low]
Older participants experienced greater problems with
uncertainty over diagnosis – including partial lung
removal before a PCD diagnosis was made – but agreed
that medical knowledge seemed to have improved. How-
ever, there was a sense of abandonment for one partici-
pant:
"There's really a change of life from being a child but I
think now, nowadays things are very different, chil-
dren are involved in their treatment and understand
their conditions so much better, partly the organisa-
tion's [PCD Support Group] done a lot for that. But
apart from us older ones then no I don't think things
will change very much at all." [2B: 61F, SI, high]
While most participants spoke of the problems due to late
diagnosis, some, despite such problems, were still trusting
of doctors, as in a participant who had had several antral
punctures to improve sinus drainage:BMC Pulmonary Medicine 2006, 6:25 http://www.biomedcentral.com/1471-2466/6/25
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"It wasn't an enjoyable process but I think well, you
know, because you accept whatever's happening
really, don't you (laughs).
Interviewer: "Where do you think that acceptance came
from?
"Faith I suppose in the doctor. I thought well he
wouldn't be doing all this if there wasn't a reason for
it. And mum wouldn't have brought me here for no
reason. I suppose it was that really." [2A: 65F, SI, low]
Mistrust of GPs
Some participants described problems with general prac-
titioners (GPs), particularly when needing antibiotics for
chest infections, with a sense of isolation due to poor
communication between GP and specialist:
"...the doctors here weren't used to that strength of
antibiotics and they didn't want to prescribe them so
at one point I had to write to the doctor here explain
what antibiotics the Brompton were telling me and
write to Doctor [...] at the Brompton can you write to
my doctor to tell him. Which he did." [3A: 49F, SI,
low]
"What they tend to do is give you Amoxicillin. If that
doesn't work they might try something else but there's
very little knowledge of PCD, certainly within my doc-
tor's surgery then I, every time I see the doctor they're
sort of a bit betwixt and between and they've seen, I've
got notes like this wad of them and I feel that maybe
that is an area where it could, maybe more liaising
with Brompton and the doctors so they're a bit more
aware rather than me having to explain it every time
that I go to them and I'd ring up the doctor's surgery
and they say can I make an appointment for two
weeks' time and I say well really need to see them soon
because damages your lungs each time." [7A: 42M, SS,
high]
However, some participants, also knew how to obtain
access to the necessary antibiotics:
"He's [GP] OK. I basically go in there and he'll say
what do you need and I'll tell him what I need and
then I'll walk out again (laughs)". [3B: 42F, SI, high]
"...it's all being proactive rather than reactive about
the, the use of these things [antibiotics], just in case,
you know, with doctors you have to wait five days for
a doctor's appointment, or you can sit and wait a few
hours in the day, I mean I don't feel like doing that. So
I'm proactive in that way and of course I'm very aware
of what I've got and how it works now". [7B: 65M, SS,
low]
Whilst the interviews suggested mistrust because of early
problems with misdiagnosis, the Royal Brompton Hospi-
tal, the tertiary referral centre where most participants
received their diagnosis, was universally praised, with
comments about participants' happiness at finally people
who understood their condition:
Interviewer: "How did you feel being at the Brompton, how
was it?
"It was great. It was almost like for the first time some-
body's listening to me and doing something that I
needed doing..." [3B: 42F, SI, high]
"I suffered with heartburn for a very long time and,
years, and I went to Brompton and they said you get
heart burn don't you and I like yeah he said give you
some tablets for that and took the tablets for two
weeks and then that cleared my heartburn up but I'd
had that for years beforehand you see". [7A: 42M, SS,
low]
Stigma questionnaire scale validation
Stigma ratings from 2005 were compared with stigma
scores from 2003 (see Table 2), and showed complete
concordance, all participants with higher stigma scores in
2003 having higher stigma ratings in 2005 (Table 2). Cal-
culating statistical significance is straightforward. For a
particular pair SW had a 50% chance of guessing which
participant had the higher stigma score. The chance prob-
ability of six correct guesses is therefore .5 × .5 × .5 × .5 ×
.5 × .5 = .56 = 1/64 = 0.01562, i.e. p < .05. In contrast,
paired t-tests on five measures of physical and mental
health (Table 3), found no significant differences, suggest-
ing SW's judgements were specific, and not secondary to
perceived health status.
Discussion
This qualitative study of PCD has identified a number of
important themes, including knowledge sharing, symp-
tom concealment, embarrassment, and mistrust of doc-
tors and medical care. The unusual methodology,
combining a questionnaire study and a focussed qualita-
tive analysis of matched sub-groups differentiated maxi-
mally on stigma scores, is an example of the hybrid
technique of "matching and thick description" [59].
Stigma
A particular interest concerns stigma, since there is no spe-
cific stereotype for PCD, and indeed no participant could
think of one. Nevertheless, nine of twelve participants
concealed their condition at some point, suggesting thatBMC Pulmonary Medicine 2006, 6:25 http://www.biomedcentral.com/1471-2466/6/25
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although the condition itself is not stigmatising, its symp-
toms may be, as Scambler suggests [44,60], particularly
given the negative status of prominent chronic productive
cough [61]. That conclusion is particularly supported in
PCD, since only a random 50% of patients show the sta-
tistically rare sign of situs inversus, and yet they seem to
show no higher levels of stigma than those with situs soli-
tus. An unusual feature of PCD being almost unknown to
the public is that some non-stigmatised participants
seemed to "enjoy", for want of any better word, the 'felt
exclusivity' of their condition (and this may be particu-
larly the case in those with situs inversus). Although stig-
matised and non-stigmatised groups report chronic cough
(and symptom scores did not differ – see Table 3), the
non-stigmatised group seemed to have assimilated PCD
into their personalities, whilst others held PCD more at a
distance, allowing a more adverse effect upon their lives,
as if the stigmatised group regarded cough as stigmatising,
whereas the non-stigmatised group regarded it merely as a
nuisance.
Knowledge of PCD
Public knowledge of PCD is very limited, so that cystic
fibrosis was sometimes used to anchor understanding of
PCD. The imbalance between the felt seriousness of PCD
and public knowledge made some participants feel iso-
lated, a frustration exacerbated by clear, specific, outward
signs. Some participants, in an attempt to decrease felt iso-
lation, traded off knowledge imbalance against increased
risk of increased stigmatisation when using the better
known CF as a knowledge anchor.
Hiding symptoms
Whilst public lack of awareness of PCD effectively means
there is no stereotype, some symptoms are very problem-
atic, making it the symptoms not the disease which is stig-
matising [60]. In the questionnaire study [15] a majority
of respondents felt embarrassed about coughing in public,
a finding consistent with other studies describing the
social burden of chronic cough [61,62,62]. The current
interviews suggested cough was the most embarrassing
feature of PCD, with most participants coughing in pri-
vate so as not to be overheard. The salience of coughing
for stigma is explained by Jones et al's [43] peril dimen-
sion, with interviewees suggesting coughing was anti-
social and not to be witnessed in public, and some indi-
viduals with PCD perceived they may be putting others at
risk through coughing. Comments about "smoker's
cough" may also refer to Jones et al's dimension of per-
ceived responsibility, a problem that may become more
problematic for people with PCD as smoking itself
becomes increasingly discredited.
Concealing PCD symptoms also means hiding treat-
ments, in particular postural drainage, with one partici-
pant missing treatment to conceal coughing.
Concealment may be associated with stress due to fears of
being stigmatised [63], a double bind since concealment
then worsens the stigmatised illness by avoidance of treat-
ment.
Mistrust of medical care
Isolation and stigma in some participants was com-
pounded by mistrust in medicine, a mistrust sometimes
present from an early age resulting from uncertainty of
diagnosis and inappropriate treatment, as also occurs in
cystic fibrosis [22]. Despite older participants saying that
current medical knowledge of PCD was superior to when
they were younger, they nevertheless felt isolation and
resentment towards medicine, the sense of isolation being
heightened by GPs' unawareness of PCD, and participants
feeling merely a "curiosity". Despite some cynicism con-
cerning medicine, some participants undoubtedly had
trust in those treating them, a trust which was sometimes
life-long.
Stigma questionnaire
As well as investigating perceptions of PCD, this study was
also designed to validate the stigma scale [15]. The perfect
correlation of SW's stigma with the previous stigma scores
suggests the questionnaire may be a useful in people liv-
ing with PCD. The questions did focus primarily on infor-
mation management, and hence felt rather than enacted
stigma, and an expanded questionnaire could take other
factors into account, particularly those contributing
towards isolation.
Questionnaire validation
Our somewhat unusual method of validation perhaps
requires further justification. SW inevitably knew that par-
ticipants were differentiated on the stigma questionnaire,
whose wording he knew (although not of course individ-
ual's responses). The questionnaire wording was derived
from other stigma measures (providing convergent valid-
ity), and corresponded to lay and social science usage of
the term 'stigma', giving content validity. Had SW had ver-
bally asked participants those exact questions, then there
would be long-term reliability over nearly three years.
However the specific wording was explicitly not used (and
indeed, despite SW discussing 'stigma' with participants,
the word itself is not in the questionnaire), so concord-
ance of questionnaire and the very different method of
assessing stigma nearly years later provides long-term pre-
dictive validity. Finally, SW's prediction was stigma spe-
cific, since not even the five contemporaneous measures
of health status in 2003 could significantly distinguish
high and low stigma groups (Table 3).BMC Pulmonary Medicine 2006, 6:25 http://www.biomedcentral.com/1471-2466/6/25
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Limitations
Whilst the concordance of the stigma ratings in 2005 with
the stigma scores from 2003 is encouraging, there should
also be some caution. SW's stigma ratings were based both
on verbal content of interviews and on body language and
non-PCD related information. Further work would bene-
fit from stigma ratings based on transcripts alone by indi-
viduals uninvolved with interviewing. Although SW the
interviewer was blind to the stigma scores, he was aware
that participants were matched within pairs, giving the
potential problem that if a participant was judged as stig-
matised, the other then had to be judged as non-stigma-
tised. A variant design could blind the interviewer both to
stigma scores and the pairings. Fortunately that design can
be implemented in a future study using stigma judge-
ments based only on the twelve transcripts.
Conclusion
Since Goffman's seminal work on stigma [41] there have
been numerous attempts to refine and further understand
the various elements that underpin stigma, although a full
understanding of stigma still remains elusive [64]. Stereo-
typing and prejudice undoubtedly form part of the proc-
ess, but embarrassment and shame are also important.
PCD is interesting for stigma research as it defies some
conentional concepts associated with stigma, as little is
known about PCD in the general population, and the out-
wardly noticeable signs are similar to those of bronchitis
or a common cold, and yet our results suggest some peo-
ple with PCD feel stigmatised and isolated, the barrier of
isolation also extending to the medical profession. Prob-
lems of uncertainty over diagnosis and perceived lack of
understanding by GPs are a worry for some people with
PCD, supporting the conclusion of a paper on best prac-
tice in care which proposed clearer lines of communica-
tion between specialist and GP [4], particularly as some
participants reported almost no specialist contact, and
hence no specialised monitoring, since initial diagnosis.
Some people with PCD may benefit from counselling,
especially those who feel isolated and stigmatised by the
condition. The ability to assess stigma in people with PCD
using a validated questionnaire may help improve sup-
port and identify those likely to benefit from counselling.
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